Scientists at the National University of Singapore (NUS) have identified a protein, DMTF1, that appears to reactivate dormant stem cells in the brain, potentially reversing age-related cognitive decline. The discovery, published in Science Advances, offers a recent avenue for research into treatments for neurodegenerative diseases and age-related memory loss.
The research centers on the decline in neurogenesis – the brain’s ability to create new neurons – that occurs with age. As individuals age, neural stem cells (NSCs) become inactive, leading to a reduction in the production of new brain cells essential for learning and memory. This decline is linked to the shortening of telomeres, protective caps on the ends of DNA strands that degrade with each cell division. When telomeres become too short, cells can no longer divide properly and either die or become senescent.
The NUS team, through comparative analysis of young and aged cells, pinpointed DMTF1 as a crucial factor. The protein functions as a transcription factor, regulating gene expression. Researchers found that younger brains have abundant DMTF1, while older brains exhibit a significant deficiency. In laboratory experiments, artificially reintroducing DMTF1 into aging cells and in aged mice stimulated the growth and division of NSCs, effectively restoring neuron production to levels observed in younger brains.
Notably, DMTF1 doesn’t repair the damaged telomeres directly. Instead, it activates auxiliary genes – Arid2 and Ss18 – that bypass the telomere-related issues and restart the neuron production cycle. This “workaround” approach is considered a significant finding, suggesting potential therapeutic strategies that don’t require addressing the fundamental problem of telomere shortening.
The Neuroscience Program at NUS, part of the Department of Anatomy, has been conducting interdisciplinary research on age-related neurodegenerative diseases, including Alzheimer’s and Parkinson’s, for some time. This latest research builds on that existing foundation, focusing on translational neuroscience aimed at repairing damaged nervous systems. The National University of Singapore is consistently ranked among the world’s top universities, providing a strong research environment for these types of studies.
While the findings are promising, researchers caution that the work is still in its early stages. The experiments have been limited to laboratory settings and animal models. Significant hurdles remain before potential human treatments can be developed, including the risk of uncontrolled cell growth and the potential for tumor formation. Future research will focus on finding the optimal balance to stimulate brain cell regeneration without triggering adverse effects.
